Ginkgo Bioworks Holdings ($DNA) Insider Trading & Smart Money Activity
Ginkgo Bioworks Holdings, Inc. ($DNA) has 2 insider trades and 3 13F position changes on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($36.05K), net -$36.05K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$36.05K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 3
- Analyst ratings on file
- 0
DNA insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 2 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 1 · $36.05K | 0 / 0 | 0 / 1 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All DNA insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | Forbes J M | Reduced | -22.54K sh | $12.54M | — | ||||||
| Insider | Coen Steven P.Chief Financial Officer | Sell (Open-market sale) 10b5-1 | 2.40K sh | $36.05K | -21.3% | — | |||||
| Insider | Christian Henry | Buy (Grant or award) | 25K sh | +14.6% | +13.1% | Read | |||||
| 13F | Belvedere Trading | Sold out | -177 sh | -11.8% | -4.1% | — | |||||
| 13F | Belvedere Trading | Sold out | -177 sh | -11.8% | -4.1% | — |
1W / 1M / 6M = how DNA moved from the trade or filing date.
Insider trading in DNA: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Coen Steven P. | Chief Financial Officer | 1 | -$36.05K | Oct 5, 2026 | |
| Christian Henry | 1 | — | Jun 11, 2026 |
Institutions moving DNA (13F)
Frequently asked questions
Are DNA insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $36.05K, a net -$36.05K.
What is the latest insider trade in DNA?
Coen Steven P., Chief Financial Officer filed a sell (open-market sale) of 2.40K sh worth $36.05K on Oct 5, 2026.
Which institutions changed their DNA positions?
Recent 13F filers moving the stock include Belvedere Trading and Forbes J M.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.